World’s largest vaccine maker halts AstraZeneca jab production
Since the middle of last year, global vaccine production has exceeded demand with the gap continuing to grow.
EU drug watchdog approves AstraZeneca Covid prevention jab
Evusheld can be used for patients with immune system problems or severe reactions to other coronavirus vaccines.
Indonesia extends AstraZeneca vaccine shelf life as 6 million doses near expiry
The decision underscores challenges many developing countries face in their slow inoculation campaigns, as vaccines donated by wealthy countries arrive with a relatively short shelf life of just a few months or even weeks.
Pfizer, AZ boosters can be given 3 months after second jab, says Khairy
The interval between the second dose and booster jab for the two vaccines was originally fixed at six months.
AstraZeneca says third jab ‘significantly’ boosts Omicron antibodies
Levels of neutralising antibodies are higher with the booster jab than with individuals who had previously been infected and recovered naturally from Covid-19.
Covax allocates 4.7 million AstraZeneca jabs to North Korea
North Korea and Eritrea are the only countries that have yet to start their vaccination campaign against Covid-19, according to the WHO.
AstraZeneca Covid-19 antibody drug offers 83% protection over 6 months
AZD7442 or Evusheld is AstraZeneca's preventative Covid-19 shot for people who do not respond well to vaccines.
Conditional approval granted for AstraZeneca, Sinovac jabs as boosters
Health DG Dr Noor Hisham Abdullah says this will apply to those who were initially vaccinated with the same type of jab.
Health ministry considering Sinovac, AstraZeneca for booster jabs
An announcement will be made once the Drug Control Authority comes to a decision.
European drug watchdog reviewing AstraZeneca anti-Covid cocktail
The drug comprises monoclonal antibodies which are administered to people already infected, to make up for deficiencies in the immune system.
AstraZeneca logs upbeat trial results from Covid drug
The group's treatment, known as AZD7442, has been undergoing phase 3 or final clinical trials to assess its safety and efficacy.
Global hits, local heroes: Covid-19 jabs around the world
An overview of more than 20 approved Covid-19 vaccines currently in use, and a few that fell by the wayside.
